Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether prazosin will:
- reduce the incidence of nightmares and sleep disturbance
- increase functioning and sense of well being in combat-trauma exposed Operation Iraqi
Freedom/Operation Enduring Freedom (OIF/OEF) Veterans.
Phase:
N/A
Details
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA) United States Department of Defense VA Puget Sound Health Care System